Tian'an Technology Group Ltd. (TANAF)
OTCMKTS
· Delayed Price · Currency is USD
15.79
+0.29 (1.87%)
At close: Sep 23, 2025
Tian'an Technology Group Revenue
Tian'an Technology Group had revenue of $471.20K in the half year ending June 30, 2025, with 117.45% growth. This brings the company's revenue in the last twelve months to $2.12M, up 1,204.15% year-over-year. In the year 2024, Tian'an Technology Group had annual revenue of $1.78M with 623.03% growth.
Revenue (ttm)
2.12M
Revenue Growth
+1,204.15%
P/S Ratio
338.77
Revenue / Employee
n/a
Employees
8
Market Cap
718.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.78M | 1.54M | 623.03% |
| Dec 31, 2023 | 246.62K | 50.89K | 26.00% |
| Dec 31, 2022 | 195.73K | 158.67K | 428.08% |
| Dec 31, 2021 | 37.07K | 10.76K | 40.88% |
| Dec 31, 2020 | 26.31K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |
| Global Cord Blood | 196.10M |